Search
for
Sort by
Research 541–570 of 1000+
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Finasteride: The First 5α-Reductase Inhibitor
- Alopecia: A Pathologist's View
- PTEN Mediates Activation of Core Clock Protein BMAL1 and Accumulation of Epidermal Stem Cells
- Endocrinology of the Aging Prostate: Current Concepts
- Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review
- The pathophysiology of delayed ejaculation
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- The Role of Non-Aromatizable Testosterone Metabolite in Metabolic Pathways
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- 5α‐Reductase inhibitors and prostatic disease
- Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors
- Comparison of clinical trials with finasteride and dutasteride.
- Novel inhibitors of 5α-reductase
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- Repeated finasteride administration induces depression-like behavior in adult male rats
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- Therapeutic Androgen Receptor Ligands
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis
- Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men.
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies